DENVER, Dec. 2 /PRNewswire-FirstCall/ -- Myogen, Inc. (Nasdaq: MYOG), a
biopharmaceutical company focused on the discovery, development and
commercialization of small molecule therapeutics for the treatment of
cardiovascular disease, today announced that Andrew D. Dickinson has joined
the company as Vice President, General Counsel and Secretary.
Prior to joining Myogen, Mr. Dickinson was a founding partner of Kendall,
Dickinson & Koenig, a corporate securities law firm, where he focused on
providing strategic advice to emerging technology companies and venture
capital firms in connection with general corporate matters, securities
compliance and significant corporate transactions, including mergers and
acquisitions, public offerings and venture capital financings. In addition,
Mr. Dickinson previously served as a corporate and securities attorney at
Cooley Godward LLP and Kirkland & Ellis LLP where he obtained extensive
experience counseling public companies and private equity firms on securities
law disclosure and compliance matters. Mr. Dickinson received a B.A. in
molecular biology from the University of Colorado at Boulder and a J.D. from
Loyola University of Chicago School of Law.
Myogen currently markets one product (Perfan(R) I.V.) in Europe for the
treatment of acute decompensated heart failure and has three product
candidates in late-stage clinical development: enoximone capsules for the
treatment of chronic heart failure, ambrisentan for the treatment of pulmonary
arterial hypertension and darusentan for the treatment of resistant
hypertension. The Company, in collaboration with Novartis, also conducts a
target and drug discovery research program focused on the development of
disease-modifying drugs for the treatment of chronic heart failure and related
cardiovascular disorders. Please visit our website at http://www.myogen.com.
SOURCE Myogen, Inc.
 back to top
Related links:
http://www.myogen.com
CONTACT:
Derek K. Cole, Director, Investor Relations
of Myogen, Inc., +1-303-464-3986, derek.cole@myogen.com
|
